EBV BMLF1 peptide GLCTLVAML (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
EBV BMLF1 peptide GLCTLVAML (HLA-A*0201)

EBV BMLF1 peptide GLCTLVAML (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from human Epstein-Barr virus (EBV) BamHI-M leftward reading frame 1 (BMLF1) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: GLCTLVAML
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

BKV LT-ag peptide LLLIWFRPV (HLA-B*0201)

BKV LT-ag peptide LLLIWFRPV (HLA-B*0201)

IBA Lifescience
Więcej
Fibromodulin F2 peptide YLQHNEIQEV (HLA-A*0201)

Fibromodulin F2 peptide YLQHNEIQEV (HLA-A*0201)

IBA Lifescience
Więcej
CMV pp65 peptide GPISGHVLK (HLA-A*1101)

CMV pp65 peptide GPISGHVLK (HLA-A*1101)

IBA Lifescience
Więcej